Circulating DNA in Breast Tumours
Author Information
Author(s): Skvortsova T E, Rykova E Y, Tamkovich S N, Bryzgunova O E, Starikov A V, Kuznetsova N P, Vlassov V V, Laktionov P P
Primary Institution: Institute of Chemical Biology and Fundamental Medicine, SD RAS
Hypothesis
Can the analysis of circulating DNA and gene methylation improve breast cancer diagnostics?
Conclusion
The study found that analyzing methylation patterns in circulating DNA can accurately differentiate between malignant and benign breast tumors.
Supporting Evidence
- The concentration of circulating DNA is higher in breast cancer patients compared to healthy individuals.
- Methylation of RARĪ²2 and RASSF1A genes was found in 95% of breast cancer patients.
- The study demonstrated that cell-surface-bound DNA provides valuable material for diagnostics.
Takeaway
Doctors can look at DNA in the blood to tell if someone has breast cancer or not, which is easier than doing surgery.
Methodology
Blood samples were collected from breast cancer patients, patients with benign tumors, and healthy donors to analyze circulating DNA and gene methylation.
Potential Biases
Potential selection bias in choosing patient samples.
Limitations
The study may not account for all variables affecting DNA levels in blood.
Participant Demographics
20 breast cancer patients, 15 patients with fibroadenoma, and 10 healthy women.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website